<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02121184</url>
  </required_header>
  <id_info>
    <org_study_id>STU00074673</org_study_id>
    <nct_id>NCT02121184</nct_id>
  </id_info>
  <brief_title>Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes</brief_title>
  <official_title>A Clinical Trial Evaluating the Interaction of Rapid Hydration and the Rate of Oxytocin Labor Augmentation on Fetal Heart Rate Changes and Maternal Fetal Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal
      status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by
      approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables
      which could affect fetal heart rate patterns at the time of initiation of analgesia, such as
      fluid administration and oxytocin management, could help us provide better care for our
      patients and their fetuses.

      Hypotheses: Patients who receive a 1000 mL fluid bolus and lower rates of oxytocin
      administration will have fewer non-reassuring fetal heart rate (FHR) changes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Informed, written consent will be obtained. At the time of request for labor analgesia, group
      assignment will be determined by opening an opaque envelope. Patients will be randomized to
      one of four groups.

      All subjects will receive a maintenance infusion of 125 mL Lactated Ringers (LR) solution
      throughout the study. For patients in Groups A or B, an intravenous bolus of 1000 mL LR will
      be initiated when the patient is positioned for epidural placement. The bolus will be
      administered through a free-flowing wide open intravenous catheter until complete.

      Patients in Groups C and D will not receive any additional fluid bolus and will only receive
      the maintenance infusion of 125 mL LR during the study period. Blinding will be maintained by
      the Labor and Delivery nurse by covering up the LR bolus fluid bag.

      If the patient is randomized to groups B or D, the dose of oxytocin currently being
      administered will be halved and not increased for the duration of the study period (60
      minutes after the initiation of CSE).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of non-reassuring fetal heart rate tracings during the first 60 minutes after the placement of epidural analgesia</measure>
    <time_frame>Request for labor analgesia up to the first 60 minutes after the epidural placement</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Pregnancy</condition>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactated Ringers bolus of 1000 mL will be initiated when the patient is positioned for epidural placement. Oxytocin management will continue as per the routine oxytocin protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactated Ringers bolus of 1000 mL will be initiated when the patient is positioned for epidural placement. A half-dose oxytocin will be initiated and not increased until 60 minutes after.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Routine oxytocin</intervention_name>
    <description>per regular oxytocin protocols</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Pitocin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Half-dose oxytocin</intervention_name>
    <description>The dose of oxytocin currently being administered will be halved and not increased until after 60 minutes initiation of labor analgesia</description>
    <arm_group_label>Group B</arm_group_label>
    <other_name>Pitocin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and over

          -  Healthy nulliparous or multiparous women

          -  Term (&gt;36 week gestation)

          -  Singleton pregnancy

          -  Spontaneous labor or spontaneous rupture of membranes

          -  Receive oxytocin

          -  Request neuraxial analgesia

        Exclusion Criteria:

          -  Under 18 years old

          -  Presence of any systemic disease (ex: diabetes mellitus, hypertension, preeclampsia

          -  Use of chronic analgesic medications

          -  Prior administration of system opioid labor analgesia

          -  Non-vertex presentation

          -  Induction of Labor

          -  Contraindication to neuraxial analgesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia Wong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert J McCarthy, PharmD</last_name>
    <phone>312-926-9015</phone>
    <email>r-mccarthy@northwestern.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prentice Women's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J McCarthy, PharmD</last_name>
      <phone>312-926-9015</phone>
      <email>r-mccarthy@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mardirosoff C, Dumont L, Boulvain M, Tramèr MR. Fetal bradycardia due to intrathecal opioids for labour analgesia: a systematic review. BJOG. 2002 Mar;109(3):274-81. Review.</citation>
    <PMID>11950182</PMID>
  </reference>
  <reference>
    <citation>Abrão KC, Francisco RP, Miyadahira S, Cicarelli DD, Zugaib M. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial. Obstet Gynecol. 2009 Jan;113(1):41-7. doi: 10.1097/AOG.0b013e31818f5eb6.</citation>
    <PMID>19104358</PMID>
  </reference>
  <reference>
    <citation>Clarke VT, Smiley RM, Finster M. Uterine hyperactivity after intrathecal injection of fentanyl for analgesia during labor: a cause of fetal bradycardia? Anesthesiology. 1994 Oct;81(4):1083.</citation>
    <PMID>7943823</PMID>
  </reference>
  <reference>
    <citation>López-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med. 1992 Feb 13;326(7):450-4.</citation>
    <PMID>1732771</PMID>
  </reference>
  <reference>
    <citation>Lindmark G, Nilsson BA. A comparative study of uterine activity in labour induced with prostaglandin F2alpha or oxytocin and in spontaneous labour. I. Pattern of the uterine contractions. Acta Obstet Gynecol Scand. 1976;55(5):453-60.</citation>
    <PMID>998176</PMID>
  </reference>
  <reference>
    <citation>Satin AJ, Leveno KJ, Sherman ML, Brewster DS, Cunningham FG. High- versus low-dose oxytocin for labor stimulation. Obstet Gynecol. 1992 Jul;80(1):111-6.</citation>
    <PMID>1603479</PMID>
  </reference>
  <reference>
    <citation>Hourvitz A, Alcalay M, Korach J, Lusky A, Barkai G, Seidman DS. A prospective study of high- versus low-dose oxytocin for induction of labor. Acta Obstet Gynecol Scand. 1996 Aug;75(7):636-41.</citation>
    <PMID>8822656</PMID>
  </reference>
  <reference>
    <citation>Merrill DC, Zlatnik FJ. Randomized, double-masked comparison of oxytocin dosage in induction and augmentation of labor. Obstet Gynecol. 1999 Sep;94(3):455-63.</citation>
    <PMID>10472877</PMID>
  </reference>
  <reference>
    <citation>Sadler LC, Davison T, McCowan LM. A randomised controlled trial and meta-analysis of active management of labour. BJOG. 2000 Jul;107(7):909-15.</citation>
    <PMID>10901564</PMID>
  </reference>
  <reference>
    <citation>Kinsella SM, Pirlet M, Mills MS, Tuckey JP, Thomas TA. Randomized study of intravenous fluid preload before epidural analgesia during labour. Br J Anaesth. 2000 Aug;85(2):311-3.</citation>
    <PMID>10992845</PMID>
  </reference>
  <reference>
    <citation>Cheek TG, Samuels P, Miller F, Tobin M, Gutsche BB. Normal saline i.v. fluid load decreases uterine activity in active labour. Br J Anaesth. 1996 Nov;77(5):632-5.</citation>
    <PMID>8957980</PMID>
  </reference>
  <reference>
    <citation>American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol. 2009 Jul;114(1):192-202. doi: 10.1097/AOG.0b013e3181aef106.</citation>
    <PMID>19546798</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>April 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2014</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Paloma Toledo</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Oxytocin</keyword>
  <keyword>Labor, Obstetric</keyword>
  <keyword>Non-reassuring fetal heart rate</keyword>
  <keyword>Epidural</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

